Welcome! The Annual Sickle Cell Disease Therapeutics Conference (SCDTC) is a forum to discuss the latest advancements and future trends for treating patients with sickle cell disease.
The Annual Sickle Cell Disease Therapeutics Conference is a forum to discuss the latest advancements and future trends for treating patients with sickle cell disease. Conference attendees will hear presentations from healthcare companies, key opinion leaders, patients, policy makers and others.
HOST
Beverley Francis-Gibson, B.A., M.A.
President & Chief Executive Officer
Sickle Cell Disease Association of America, Inc.
KEYNOTE SPEAKER
The Honorable Robin Kelly
Chair
Congressional Black Caucus Health Brain Trust
United States House of Representatives
PANELISTS AND SPEAKERS
Biree Andemariam, M.D.
Associate Professor, Hematology/Oncology
Director, New England Cell Institute, University of Connecticut
Chief Medical Officer, SCDAA
Dr. Lakiea Bailey, Ph.D.
Founder
Sickle Cell Community Consortium
Velvet Brown-Watts
Founder-Chairperson
Supporters of Families with Sickle Cell Disease
Dr. Chuck Chesson, Ph.D.
Director
Sickle Cell Disease Clinical Trials Network
Jew-EL Darbone
Sickle Cell Patient Advocate
Jeremie Estepp, M.D.
Medical Director
Clinical Translation Program in Hematology
St. Jude Children’s Research Hospital
Andre Harris, CHW
Sickle Cell Patient Advocate
Greg Kato, M.D.
Professor of Medicine
Director of the Adult Sickle Cell Center of Excellence for
the UPP Division of Hematology-Oncology
University of Pittsburgh Medical Center
Allison King, M.D., M.P.H., Ph.D.
Associate Professor of Occupational Therapy, Pediatrics,
Medicine, Surgery (Prevention and Control) and Education
Washington University School of Medicine
Hertz Nazaire (Naz)
Sickle Cell Patient Advocate
